Quantitative proteomic analysis of sokotrasterol sulfate-stimulated primary human endothelial cells

被引:13
作者
Karsan, A
Pollet, I
Yu, LR
Chan, KC
Conrads, TP
Lucas, DA
Andersen, R
Veenstra, T
机构
[1] British Columbia Canc Agcy, Dept Med Biophys & Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada
[2] NCI, Lab Proteom & Anal Technol, SAIC Frederick Inc, NIH, Frederick, MD 21702 USA
[3] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada
关键词
D O I
10.1074/mcp.M400152-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The endothelium forms a continuous monolayer at the interface between blood and tissue and contributes significantly to the sensing and transducing of signals between blood and tissue. New blood vessel formation, or angiogenesis, is initiated by the activation of endothelial cells and is an important process required for various pathological and physiological situations. This study used cleavable isotope-coded affinity tag reagents combined with mass spectrometry to investigate the molecular basis of a recently discovered angiogenesis-promoting steroid, sokotrasterol sulfate. Changes in the relative abundances of over 1000 proteins within human endothelial cells treated with sokotrasterol sulfate and vehicle-treated cells were identified and quantitated using this technique. A method that examines the entire ensemble of quantitative measurements was developed to identify proteins that showed a statistically significant change in relative abundance resulting from treatment with sokotrasterol sulfate. A total of 93 proteins was significantly up-regulated, and 37 were down-regulated in response to sokotrasterol sulfate stimulation of endothelial cells. Among the up-regulated proteins, several were identified that are novel to endothelial cells and are likely involved in cell communication and morphogenesis. These findings are consistent with a role for sokotrasterol sulfate in endothelial sprouting.
引用
收藏
页码:191 / 204
页数:14
相关论文
共 40 条
[1]
Dysferlin and the plasma membrane repair in muscular dystrophy [J].
Bansal, D ;
Campbell, KP .
TRENDS IN CELL BIOLOGY, 2004, 14 (04) :206-213
[2]
Proteomic study of human umbilical vein endothelial cells in culture [J].
Bruneel, A ;
Labas, V ;
Mailloux, A ;
Sharma, S ;
Vinh, J ;
Vaubourdolle, M ;
Baudin, B .
PROTEOMICS, 2003, 3 (05) :714-723
[3]
Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases [J].
Cao, YH ;
O'Reilly, MS ;
Marshall, B ;
Flynn, E ;
Ji, RW ;
Folkman, J .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1055-1063
[4]
Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders [J].
Carmeliet, P ;
Storkebaum, E .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2002, 13 (01) :39-53
[5]
Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[6]
Vascular endothelial growth factor enhances atherosclerotic plaque progression [J].
Celletti, FL ;
Waugh, JM ;
Amabile, PG ;
Brendolan, A ;
Hilfiker, PR ;
Dake, MD .
NATURE MEDICINE, 2001, 7 (04) :425-429
[7]
Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer [J].
Dabrosin, C ;
Margetts, PJ ;
Gauldie, J .
INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (04) :535-540
[8]
Ischemia-driven angiogenesis [J].
Dor, Y ;
Keshet, E .
TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (08) :289-294
[9]
ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[10]
Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763